TR199701051A2 - 2' -Fluoro-5-metil-�-l-arabino-furanosil�ridin haz�rlanma prosesi - Google Patents

2' -Fluoro-5-metil-�-l-arabino-furanosil�ridin haz�rlanma prosesi

Info

Publication number
TR199701051A2
TR199701051A2 TR97/01051A TR9701051A TR199701051A2 TR 199701051 A2 TR199701051 A2 TR 199701051A2 TR 97/01051 A TR97/01051 A TR 97/01051A TR 9701051 A TR9701051 A TR 9701051A TR 199701051 A2 TR199701051 A2 TR 199701051A2
Authority
TR
Turkey
Prior art keywords
methyl
furanosylridine
arabino
fluoro
preparation process
Prior art date
Application number
TR97/01051A
Other languages
English (en)
Turkish (tr)
Other versions
TR199701051A3 (tr
Inventor
Kwang Chu Chung
Du Jinfa
Seok Choi Yong
Original Assignee
The University Of Georgia Research Foundation Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University Of Georgia Research Foundation Inc. filed Critical The University Of Georgia Research Foundation Inc.
Publication of TR199701051A3 publication Critical patent/TR199701051A3/tr
Publication of TR199701051A2 publication Critical patent/TR199701051A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02Monosaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR97/01051A 1997-07-23 1997-09-26 2' -Fluoro-5-metil-�-l-arabino-furanosil�ridin haz�rlanma prosesi TR199701051A2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5348897P 1997-07-23 1997-07-23

Publications (2)

Publication Number Publication Date
TR199701051A3 TR199701051A3 (tr) 1999-03-22
TR199701051A2 true TR199701051A2 (xx) 1999-03-22

Family

ID=21984622

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01051A TR199701051A2 (xx) 1997-07-23 1997-09-26 2' -Fluoro-5-metil-�-l-arabino-furanosil�ridin haz�rlanma prosesi

Country Status (21)

Country Link
US (2) US6512107B2 (en:Method)
EP (2) EP0998482B1 (en:Method)
KR (1) KR100247505B1 (en:Method)
CN (1) CN1113892C (en:Method)
AR (1) AR009092A1 (en:Method)
AT (2) ATE304547T1 (en:Method)
AU (1) AU8758298A (en:Method)
BR (1) BR9810804B1 (en:Method)
DE (2) DE69831619T2 (en:Method)
DK (1) DK1327637T3 (en:Method)
ES (2) ES2249678T3 (en:Method)
ID (1) ID20624A (en:Method)
IL (1) IL121730A (en:Method)
IN (1) IN186807B (en:Method)
MY (1) MY117314A (en:Method)
PT (2) PT1327637E (en:Method)
SA (1) SA98180771B1 (en:Method)
SI (1) SI1327637T1 (en:Method)
TR (1) TR199701051A2 (en:Method)
TW (1) TW434252B (en:Method)
WO (2) WO1999005157A1 (en:Method)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW434252B (en) 1997-07-23 2001-05-16 Univ Georgia Res Found Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine
KR100449618B1 (ko) * 1998-03-27 2004-11-16 부광약품 주식회사 2'-플루오로-5-메틸-β-L-아라비노푸라노실유리딘의 제조방법
US6462191B1 (en) * 2000-07-13 2002-10-08 Air Products And Chemicals, Inc. Synthesis of 2-deoxy-2-fluoro-arabinose derivatives
DE60204859T2 (de) * 2001-03-30 2006-04-27 Gilead Sciences, Inc., Foster City Verfahren zur Herstellung von 2'-Halo-beta-L-arabino-furanosylnucleosiden
KR100487992B1 (ko) * 2001-10-25 2005-05-09 부광약품 주식회사 2'-플루오로-5-메틸-β-엘-아라비노푸라노실유리딘의 황유도체
US7211570B2 (en) * 2001-12-20 2007-05-01 Pharmasset, Inc. Treatment of EBV and KHSV infection
KR100976778B1 (ko) 2003-04-17 2010-08-18 부광약품 주식회사 1-(2'-플루오로-베타-엘-아라비노푸라노실)티민의 황 유도체를 유효 활성 성분으로 하는 b형 간염 바이러스 치료제
SG158136A1 (en) 2004-09-14 2010-01-29 Pharmasset Inc Preparation of 2`-fluoro-2`- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
MX2007015534A (es) 2005-06-07 2008-02-25 Univ Yale Metodos para tratar el cancer y otras condiciones o estados de enfermedad utilizando la 2'-fluoro-5-metil-beta-l-arabinofuranosiluridina y la beta -l-2'-d soxirribofuranosiltimidina.
CN101328171A (zh) 2007-06-18 2008-12-24 张中能 一种溴苯基-取代的噻唑二氢嘧啶
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
US11760773B2 (en) 2018-02-02 2023-09-19 Maverix Oncology, Inc. Small molecule drug conjugates of gemcitabine monophosphate
CN109320564B (zh) * 2018-10-26 2022-05-31 浙江晟格生物科技有限公司 一种l-来苏糖的制备工艺
CN109467541A (zh) * 2018-11-17 2019-03-15 扬州工业职业技术学院 一种绿色合成克拉夫定药物中间体的方法
CN109467583A (zh) * 2018-11-17 2019-03-15 扬州工业职业技术学院 一种克拉夫定的绿色合成工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3714473A1 (de) * 1987-04-30 1988-11-10 Basf Ag Kontinuierliches verfahren zur epimerisierung von zuckern, insbesondere von d-arabinose zu d-ribose
JP2784230B2 (ja) 1988-02-09 1998-08-06 ユーオーピー・インコーポレーテッド エピマーアルドースおよびアルドース同族体の連続相互変換に用いる固体触媒
DE4002727A1 (de) * 1990-01-31 1991-08-01 Bayer Ag Mischungen aus waessrigen polymerdispersionen
US5587362A (en) 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
US5808040A (en) 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
TW434252B (en) * 1997-07-23 2001-05-16 Univ Georgia Res Found Process for the preparation of 2'-fluoro-5-methyl-β-L-arabino-furanosyluridine

Also Published As

Publication number Publication date
AU8758298A (en) 1999-02-16
DE69831619D1 (de) 2005-10-20
PT998482E (pt) 2003-08-29
IL121730A0 (en) 1998-02-22
DK1327637T3 (da) 2006-01-16
MY117314A (en) 2004-06-30
TR199701051A3 (tr) 1999-03-22
IL121730A (en) 2005-03-20
WO1999005158A1 (en) 1999-02-04
CN1206012A (zh) 1999-01-27
SA98180771B1 (ar) 2006-10-29
US6894159B2 (en) 2005-05-17
DE69812959T2 (de) 2004-03-04
EP0998482A1 (en) 2000-05-10
BR9810804B1 (pt) 2012-01-10
ATE304547T1 (de) 2005-09-15
ID20624A (id) 1999-01-28
PT1327637E (pt) 2005-11-30
IN186807B (en:Method) 2001-11-10
CN1113892C (zh) 2003-07-09
DE69831619T2 (de) 2006-06-14
BR9810804A (pt) 2000-09-12
DE69812959D1 (de) 2003-05-08
ES2195370T3 (es) 2003-12-01
EP1327637A1 (en) 2003-07-16
US20020062018A1 (en) 2002-05-23
US6512107B2 (en) 2003-01-28
EP1327637B1 (en) 2005-09-14
EP0998482B1 (en) 2003-04-02
TW434252B (en) 2001-05-16
KR100247505B1 (ko) 2000-03-15
KR19990013297A (ko) 1999-02-25
WO1999005157A1 (en) 1999-02-04
ATE236187T1 (de) 2003-04-15
AR009092A1 (es) 2000-03-08
US20030139593A1 (en) 2003-07-24
ES2249678T3 (es) 2006-04-01
SI1327637T1 (sl) 2005-12-31

Similar Documents

Publication Publication Date Title
TR199701051A2 (xx) 2' -Fluoro-5-metil-�-l-arabino-furanosil�ridin haz�rlanma prosesi
CA2145661A1 (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
WO1995030670A3 (en) Pyranone compounds useful to treat retroviral infections
CA2301000A1 (en) An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine
SI0887427T1 (sl) Pomnozevanje in detekcija HIV-1 in/ali HIV-2
DE3784484D1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.
AU5285899A (en) Anti hepatitis c virus antibody and uses thereof
PL321966A1 (en) Vaccine against viral hepatitis of b type
FI955224L (fi) Hepatiitti-C-virustyypit 4,5 ja 6
EP0806205A3 (en) Urea, thiourea and guanidine compounds and their use as anti-viral agents
PT892801E (pt) Compostos derivados de acridona uteis como agentes antineoplasicos e antiretrovirais
ZA9811316B (en) Novel hepatitis C virus NS5B protein
TR200002140T2 (tr) Naftil-ve anilid ile değiştirilmiş yeni sülfonamidler
FI923099L (fi) Biomassa foer att producera virus/ virusantigen.
ES2081286T3 (es) Nucleosidos de pirimidina antivirus del sida.
ZA978351B (en) Immunogenic peptides of foot-and-mouth disease viruses.
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
AU3170193A (en) Therapeutic nucleosides
TR199901535A2 (en) Siklooksigenaz �nleyicisi.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
EP0674657A4 (en) GP41 MUTANTS AND THEIR USE AS THERAPEUTIC AGENTS AGAINST HIV.
HU9802020D0 (en) Improved process for the preparation of unsymmetrical 4,6-bis(aryloxy)-pyrimidine derivatives
NO992501L (no) Fremgangsmåte ved fremstilling av 2-amin-2-imidazolin-, guanidin- og 2-amin-3,4,5,6-tetrahydropyrimidin-derivater
WO1995025806A3 (en) Packaging-deficient lentiviruses
WO1998001570A3 (en) Mutated antibody-dependent infection enhancing domains of hiv